The global transmembrane prolyl 4 hydroxylase market is anticipated to grow at a significant CAGR during the forecast period. Transmembrane prolyl 4-hydroxylase (P4H-TM) is a member of the P4H family. Additionally, biallelic loss of function P4H-TM mutations causes a syndromic form of severe cognitive impairment in humans. The major factor driving the demand for transmembrane prolyl 4 hydroxylase market is the increasing prevalence of colitis across the globe.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/transmembrane-prolyl-4-hydroxylase-market
According to the National Center for Biotechnology Information (NCBI), ulcerative colitis has an incidence rate of 9 to 20 cases per 100,000 persons per year globally. Additionally, its prevalence is 156 to 291 cases per 100,000 persons per year across the globe. Furthermore, it has a greater prevalence in adults compared to Crohn’s disease. Hence, the increasing prevalence of colitis is driving the demand for transmembrane prolyl 4 hydroxylase.
Moreover, North America hold a prominent share in the market owing to the presence of an advanced healthcare infrastructure as well as the presence of key players in the region. Additionally, the market is also growing due to the increasing application of transmembrane prolyl 4 hydroxylase in several diseases such as inflammatory bowel disease, among others. Some major players in the market include Astellas Pharma Inc., and GlaxoSmithKline Plc, among others.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Astellas Pharma Inc., and GlaxoSmithKline Plc, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Transmembrane Prolyl 4 Hydroxylase Market Report by Segment
By Type
- Daprodustat
- Dimethyloxalylglycine
- FG-22216
- FG-4497
- Others
By Application
- Anemia
- Inflammatory Bowel Dosease
- Brain
- Edema
- Colitis
- Others
A full report of Transmembrane Prolyl 4 Hydroxylase Market is available at: https://www.omrglobal.com/industry-reports/transmembrane-prolyl-4-hydroxylase-market
Transmembrane Prolyl 4 Hydroxylase Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Astellas Pharma Inc.
- GlaxoSmithKline Plc
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
